20%w/v dextrose injection, usp solution for injection
pharmaceutical solution industries (psi), saudi arabia - dextrose - solution for injection - 20 %
martindale pharma® acetylcysteine 200mg/ml injection
max health limited - acetylcysteine 20%{relative} - concentrate for infusion - 20% w/v - active: acetylcysteine 20%{relative} excipient: disodium edetate sodium hydroxide - n-acetylcysteine is indicated for the treatment of paracetamol overdose in patients: · who present within 15 hours after an acute overdose with a plasma paracetamol level on or above a line joining points of 150mg/l at 4h and 20mg/l at 15h (see nomogram below) or · who have taken more than 200mg/kg or 10g (whichever is less) of sustained release paracetamol or have one of two serum paracetamol levels taken four hours apart on or above a line joining points of 150mg/l at 4h and 20mg/l at 15h (see nomogram below) or · who have taken an acute overdose of paracetamol with opiates or medicines with anticholinergic effects and have one of two serum paracetamol levels taken four hours apart on or above a line joining points of 150mg/l at 4h and 20mg/l at 15h (see nomogram below) or · where there is any doubt over the time of an acute overdose, irrespective of plasma paracetamol level or · who present more than 15 hours after an overdose with abnormal liver biochemistry (inr >1.3 and/or alt>150) or fulminant hepatic failure or · who have taken a staggered overdose irrespective of plasma paracetamol level. staggered is defined as an overdose of 200mg/kg or 10g (whichever is less) over a single 24 hour period or 150mg/kg of 6g (whichever is less) per 24 hour period for at least 48 hours.
albumex 20
csl behring (nz) ltd - albumin 200 g/l (albumin ex nz) - solution for infusion - 20% w/v - active: albumin 200 g/l (albumin ex nz) excipient: octanoate ions sodium water for injection - hypoproteinaemia in the acutely ill patient; albumex® 20 is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy.
osmitrol
baxter healthcare ltd - mannitol 20% - solution for infusion - 20 % - active: mannitol 20% excipient: water for injection - osmitrol intravenous infusion can be used in - the promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established;
pitressin
link pharmaceuticals ltd - argipressin 20 pressor units/ml (7.5% overage added) - solution for injection - 20 pressor units/ml - active: argipressin 20 pressor units/ml (7.5% overage added) excipient: glacial acetic acid water for injection - pitressin is indicated for prevention and treatment of post-operative abdominal distention in abdominal radiography to dispel interfering gas shadows and in diabetes insipidus.
posalfilin
carsl consulting - podophyllum resin 20%{relative}; salicylic acid 25%{relative} - topical ointment - 20%/25% - active: podophyllum resin 20%{relative} salicylic acid 25%{relative} excipient: liquid paraffin yellow soft paraffin
structolipid 20%
fresenius kabi new zealand limited - structured triglycerides 200 g/l (64:36 ratio of long chain:medium chain triglycerides); ; - emulsion for infusion - 20% w/v - active: structured triglycerides 200 g/l (64:36 ratio of long chain:medium chain triglycerides) excipient: egg lecithin glycerol nitrogen sodium hydroxide water for injection
butrans 20 micrograms/hour transdermal patch
imbat limited - buprenorphine - transdermal patch - 20 microgram per hour - oripavine derivatives; buprenorphine
butrans 20 micrograms/hour transdermal patch
mundipharma pharmaceuticals limited - buprenorphine - transdermal patch - 20 milligram(s) - oripavine derivatives; buprenorphine
caverject 20 micrograms powder and solvent for solution for injection
pfizer healthcare ireland - alprostadil - powder and solvent for solution for injection - 20 microgram(s) - drugs used in erectile dysfunction; alprostadil